Study of effects of antiglaucoma eye drops on glaucomatous optic neuropathy and ocular serface.
Study of effects of antiglaucoma eye drops on glaucomatous optic neuropathy and ocular serface.
批准号:
16591738
负责人:
OHGURO Ikuyo
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
目的:目的:研究抗青光眼滴眼液对N-甲基-D-天冬氨酸(NMDA)诱导的视网膜损伤及眼表的影响。用几种抗青光眼滴眼液、β-受体阻滞剂、α/β-受体阻滞剂、α_1受体阻滞剂、α_2受体激动剂和前列腺素衍生物局部给药于NMDA处理的大鼠眼和未处理的大鼠眼,观察视网膜厚度、逆行标记视网膜神经节细胞(RGC)数量、结果:玻璃体内注射NMDA可使视网膜层厚度明显减少,并诱导胶质细胞增生蛋白(GFAP)表达上调。局部给予β受体阻滞剂和前列腺素衍生物对视网膜厚度、RGCs数量或GFAP表达几乎没有显著影响。而α/β受体阻滞剂、α 1受体阻滞剂和α 2受体激动剂对视网膜厚度和RGCs数量有保护作用,并能显著抑制NMDA诱导的GFAP表达上调。在1101个与细胞调节机制相关的基因中,胰岛素样生长因子IGF-1和ErbB 3的两个基因的表达在α/β阻断剂、α_1阻断剂和α_2激动剂给药后发生改变。结论:抗青光眼滴眼液通过调节α肾上腺素能受体(α 1受体阻滞剂和α 2受体激动剂),对NMDA诱导的大鼠视网膜损伤具有保护作用。α/β受体阻滞剂、α_1受体阻滞剂和前列腺素衍生物可诱导ECM降解,影响滤过手术。
英文摘要
Purpose : To study the effects of antiglaucoma eye drops on N-methyl-D-aspartate (NMDA)-induced retinal damage and ocular surfaceMethods : Several antiglaucoma eye drops, β-blockers, α/β-blockers, an α_1-blocker, and α_2-agonist, and a prostaglandin derivative, were topically administrated to NMDA-treated rat eyes or non-treated rat eye, and the retinal thickness, the number of retrograde-labeled retinal ganglion cells (RGCs), the results of a cDNA microarray analysis, and the levels of matrix metalloprotease (MMP) and tissue inhibitor of matrix protease (TIMP) which regulate the metabolism of the extracellular matrix (ECM) were studied.Results : Intravitreal administration of NMDA caused a significant decrease in the thickness of the retinal layers and induced upregulation of glial fibrillary protein (GFAP). Topical administration of β-blockers and a prostaglandin derivative showed almost no significant effects on retinal thickness, the number of RGCs, or expression of GFAP. In contrast, the α/β-blockers, the α_1-blocker, and the α_2-agonist showed preservation effects on retinal thickness and the the number of RGCs, and marked suppression of NMDA-induced upregulation of GFAP. Among 1101 genes related to cellular regulatory mechanisms, the expression of two genes, both for insulin-like growth factors, IGF-1 and ErbB3,was altered upon administration of the α/β-blockers, the α_1-blocker, and the α_2-agonist. In addition, topical administration of the α/β-blockers, the α_1-blocker, and the prostaglandin derivative induced upregulation of MMP and downregulation of TIMP of conjunctiva.Conclusion : Our present study suggests that modulations of the α-adrenergic receptor, α_1-blocking, and α_2-stimulation, by antiglaucoma eye drops may cause beneficial effects on NMDA-induced retinal damage in the rat. Our results also suggests that the α/β-blockers, the α_1-blocker, and the prostaglandin derivative induce degradation of ECM, affcting filter surgery.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
緑内障セミナー 48.緑内障と自己免疫疾患
青光眼研讨会48.青光眼与自身免疫性疾病
DOI:
--
发表时间:
2004
期刊:
あたらしい眼科 21
影响因子:
--
作者:
[大黒幾代, ほか]
通讯作者:
ほか
緑内障性視神経障害における眼圧非依存因子の検討-血小板凝集能との係わり-
青光眼性视神经病变眼压非依赖性因素的检查-与血小板聚集能力的关系-
DOI:
--
发表时间:
2005
期刊:
あたらしい眼科 22
影响因子:
--
作者:
[大黒幾代, 大黒 浩, 他]
通讯作者:
他
Effects of matrix metalloproteinase-3 gene transfer by electroporation in glaucoma filter surgery.
电穿孔基质金属蛋白酶 3 基因转移在青光眼滤过性手术中的效果。
DOI:
--
发表时间:
2004
期刊:
Exp Eye Res 79
影响因子:
--
作者:
[Mamiya K, Ohguro I, et al.]
通讯作者:
et al.
正常眼圧にもかかわらず、緑内障様視野異常や角膜径増大を呈した発達緑内障疑いの2例
疑似发育性青光眼两例,尽管眼压正常,但出现青光眼样视野异常和角膜直径增大
DOI:
--
发表时间:
2005
期刊:
眼科 47
影响因子:
--
作者:
[大黒幾代, 大黒 浩, 他]
通讯作者:
他
Optic disc characteristics assessed by evaluation of clinical optic disc photographs in glaucoma patients.
通过评估青光眼患者的临床视盘照片来评估视盘特征。
DOI:
--
发表时间:
2005
期刊:
Hirosaki Med. J. 57
影响因子:
--
作者:
[Ohguro I, Ohguro H, et al.]
通讯作者:
et al.
共 14 条
Study of autoimmune mechanisms in molecular pathology of glaucomatous optic neuropathy.
-
批准号:14571653
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:OHGURO Ikuyo
-
依托单位:
国内基金
海外基金
酸敏感离子通道功能与调控机理研究
-
批准号:30830035
-
项目类别:重点项目
-
资助金额:190.0万元
-
批准年份:2008
-
负责人:徐天乐
-
依托单位: